Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Guoying
Contact Guoying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease
Future MicrobiologyAhead of Print Plain Language Summary of PublicationOpen Access Abstract What is this summary about? Invasive aspergillosis (also known as IA) is a type of fungal infection, caused by a species of fungus called Aspergillus, that can be life threatening. Isavuconazole and voriconazole belong to a group of antifungal drugs called triazoles that are recommended for treating IA. In the USA and in Europe, isavuconazole is approved for treating patients with IA.
Evaluation of the Effect of Contezolid (MRX-I) on the Corrected QT Interval in a Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study in Healthy Chinese Volunteers
Clinical Therapeutics Junzhen Wu, Guoying Cao, Hailan Wu, Yuancheng Chen, Beining Guo, Xiaojie Wu, Jicheng Yu, Kanhong Ni, Jin Qian, Li Wang, Jufang Wu, Yu Wang, Hong Yuan, Jing Zhang, Yuewen Xi DOI: 10.1128/AAC.02158-19 ABSTRACT Contezolid (MRX-I), a new oxazolidinone, is an antibiotic in development for treating complicated skin and soft tissue infections caused by resistant Gram-positive bacteria.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Guoying
Contact Guoying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack